Table 4b.
Multivariate overall survival analysis.
| HR | 2.5% | 97.5% | p | |
|---|---|---|---|---|
| Histology (endometrioid ref.) other | 1.506 | 1.058 | 2.144 | 0.023 |
| Age | 1.052 | 1.035 | 1.070 | <0.001 |
| Race (White ref.) Hispanic | 2.702 | 1.297 | 5.629 | 0.008 |
| Black | 1.210 | 0.610 | 2.402 | 0.585 |
| Other | 1.342 | 0.672 | 2.679 | 0.405 |
| Performance status (0 ref.) 1, 2, 3 | 1.463 | 0.937 | 2.284 | 0.094 |
| Positive washings (no ref.) yes | 1.898 | 1.274 | 2.827 | 0.002 |
| Stage (IA ref.) IB | 1.262 | 0.752 | 2.116 | 0.379 |
| II | 1.672 | 0.784 | 3.566 | 0.183 |
| IIIA | 1.437 | 0.600 | 3.441 | 0.416 |
| IIIC1 | 2.692 | 1.569 | 4.618 | <0.001 |
| IIIC2 | 4.310 | 2.549 | 7.286 | <0.001 |
| IVB | 11.533 | 6.518 | 20.408 | <0.001 |
| Adjuvant treatment (observation ref.) chemotherapy | 0.481 | 0.272 | 0.850 | 0.012 |
| Radiation | 0.975 | 0.642 | 1.482 | 0.907 |
| Both | 1.091 | 0.662 | 1.799 | 0.733 |